Focal Segmental Glomerulosclerosis
Clinical Trial

Nephrology

FSGS Clinical Trials

Living with FSGS can be challenging, especially as symptoms like swelling, fatigue, and changes in kidney function begin to affect everyday life. At Total Research Group, we are conducting focal segmental glomerulosclerosis clinical trials in Miami to evaluate the efficacy of an investigational drug and understand whether it can improve kidney health for those living with this condition.

This FSGS research study in Miami focuses on evaluating the treatment under strict safety protocols and continuous medical supervision. Participants will receive regular health evaluations, close monitoring, and compassionate support throughout their journey. By taking part, individuals not only receive attentive care but also help researchers better understand FSGS and explore potential treatment options for the future.

Benefits of Participating

With expert guidance and structured follow-up, participants also receive:

  •  Patient-first safety standards and ethical study practices
  • Modern research facilities with experienced investigators
  • Access to innovative treatment options and close health monitoring
  • Personalized medical attention from certified research professionals
  • Opportunity to support future care while receiving dedicated support throughout the study
  • Compensation may be available for time and travel

Apply for Study

This field is for validation purposes and should be left unchanged.

Get Started: What to Expect?

If you or a loved one is interested in joining our FSGS clinical trials, our team will connect with you after you submit your information to review eligibility and guide you through the next steps. We will clearly explain the purpose of the study, what participation involves, and answer any questions so you can make an informed decision.

If you qualify, you will be invited for a screening visit where experienced healthcare professionals will conduct medical assessments and review your health history. The study doctor will explain how the investigational drug works, possible benefits, and the safety measures in place throughout the trial. Our team is here to support you with care, transparency, and clear communication at every stage.

Participate Today

Age

12 Years and Older

Gender

All

Condition

Focal Segmental Glomerulosclerosis (FSGS)

Location

Miami, Florida

About Focal Segmental Glomerulosclerosis (FSGS)

FSGS is a kidney condition that causes scarring in parts of the glomeruli, which are responsible for filtering waste from the blood. Over time, this scarring can reduce kidney function and lead to complications such as proteinuria, swelling, high blood pressure, and fatigue. The condition may develop due to genetic factors, underlying health conditions, or other causes, and it often requires long-term management.

Despite current treatment options, FSGS remains a complex condition, and more research is needed to better understand how to slow its progression and improve outcomes. Ongoing focal segmental glomerulosclerosis clinical trials play an important role in exploring new therapies that may offer better support and improved quality of life for individuals living with this condition.

Frequently Asked Questions

An FSGS clinical trial evaluates investigational treatments to determine whether they are safe and effective in improving kidney health for people living with FSGS.

Adults and adolescents diagnosed with FSGS may be eligible. Our research team will review your medical history to determine if the study is a good fit.

Participants may receive access to investigational treatments, additional medical monitoring, and the opportunity to contribute to research that may improve future kidney care.

You can submit your interest through the contact form or phone number provided. A study coordinator will reach out to guide you through the next steps.

Yes, participation is completely voluntary, and you may withdraw at any time without affecting your regular medical care.